Get the latest news and updates from ORI.
ORI released forecasts for three funding opportunity announcements (FOAs) for research integrity grants, including a new Program Development and Evaluation (PDE) program. ORI will continue to support the Research on Research Integrity (RRI) and the Research Integrity Conferences (RIC) grant programs.
This free workshop will explore issues around conceptions of privacy, ways to protect data confidentiality, and how IRBs and review bodies can learn more about protections and ethical oversight of important research.
ORI found that Dr. Rahul Agrawal, former visiting fellow at the Center for Cancer Research, Laboratory of Pathology, Cancer Molecular Pathology Section, National Cancer Institute (NCI), NIH, engaged in research misconduct in research supported by the Intramural Research Program of NCI, NIH.
Alexander Runko, Ph.D., starting Aug. 4, will be the new Director of ORI’s Division of Investigative Oversight (DIO).
Adm. Brett P. Giroir, M.D., HHS Assistant Secretary for Health, announced today that Elisabeth Handley will join the Office of Research Integrity as the Interim Director.
Dr. Wanda Jones, who was ORI's Interim Director, has been permanently named as ORI's Deputy Director and will serve as Acting Director.
ORI found that William W. Cruikshank, Ph.D. (Respondent), former Professor of Medicine, Pulmonary Center, BU School of Medicine engaged in research misconduct in research supported by National Cancer Institute (NCI), National Institutes of Health (NIH).